Texas Top Legal Officer Files Lawsuit Against Tylenol Producers Over Autism Assertions

Legal Case
Ken Paxton, a Trump ally who is running for US Senate, claimed pharmaceutical manufacturers of concealing the risks of Tylenol

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms withheld safety concerns that the pain reliever presented to children's neurological development.

This legal action comes a month after Donald Trump promoted an unsubstantiated connection between consuming acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which formerly manufactured the medication, the exclusive pain medication recommended for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he stated they "deceived the public by making money from suffering and promoting medication ignoring the dangers."

The company states there is no credible evidence tying acetaminophen to autism.

"These corporations lied for decades, deliberately risking countless individuals to boost earnings," Paxton, a Republican, said.

Kenvue commented that it was "very worried by the spread of false claims on the safety of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its website, Kenvue also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a proven link between taking paracetamol and autism spectrum disorder."

Associations representing physicians and health professionals share this view.

ACOG has said acetaminophen - the key substance in acetaminophen - is one of the few options for expectant mothers to treat pain and fever, which can create serious health risks if left untreated.

"In more than two decades of research on the use of acetaminophen in gestation, not a single reputable study has successfully concluded that the usage of paracetamol in any period of gestation results in neurological conditions in young ones," the group commented.

The lawsuit references current declarations from the former administration in claiming the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he instructed expectant mothers to "struggle intensely" not to consume Tylenol when ill.

The FDA then issued a notice that doctors should think about restricting the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in children has remains unverified.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would establish the source of autism in a matter of months.

But experts advised that finding a unique factor of autism - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would be difficult.

Autism spectrum disorder is a type of lifelong neurodivergence and impairment that impacts how persons experience and engage with the world, and is identified using doctors' observations.

In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - asserts the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "destroy any marketing or advertising" that states Tylenol is safe for women during pregnancy.

The court case echoes the grievances of a assembly of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

Judicial authorities threw out the case, saying investigations from the parents' expert witnesses was lacking definitive proof.

Jennifer Hill
Jennifer Hill

A passionate gamer and tech enthusiast with over a decade of experience in game journalism and community building.